Viewing Study NCT02549261


Ignite Creation Date: 2025-12-24 @ 12:22 PM
Ignite Modification Date: 2026-02-25 @ 6:59 PM
Study NCT ID: NCT02549261
Status: UNKNOWN
Last Update Posted: 2015-09-15
First Post: 2015-08-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Nimotuzumab in Combination With Radiochemotherapy for Patients With Stage IIIA/IIIB Non-small Cell Lung Cancer
Sponsor: Biotech Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module